Literature DB >> 2535056

Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.

W Linz1, B A Schölkens, J Kaiser, M Just, B Y Qi, U Albus, P Petry.   

Abstract

We investigated the influence of the angiotensin-converting enzyme (ACE) inhibitor ramipril on cardiac arrhythmias in guinea pigs and rats. Ramiprilat, the active moiety of ramipril, did not influence action potentials of isolated guinea-pig papillary muscle or rabbit sinus node, thereby excluding cellular electrophysiological evidence of anti-arrhythmic properties. Ramipril protected against cardiac arrhythmias induced by digoxin infusion in guinea pigs. This effect was comparable with that of lidocaine. In isolated perfused ischemic working rat hearts, angiotensin (ANG) I (3 x 10(-9) M/l) and ANG II (1 x 10(-9) M/l) aggravated reperfusion arrhythmias, accompanied by deterioration of cardiodynamic and metabolic events. Bradykinin (BK) (1 x 10(-10)-1 x 10(-8) M/l), in contrast, protected against reperfusion arrhythmias, which corresponded to an increase in energy-rich phosphates and glycogen stores and a decrease in lactate levels in myocardial tissue. Identical changes were seen in hearts from rats pretreated with ramipril (1 mg/kg PO) or perfused with ramiprilat (2.58 x 10(-7)-2.58 x 10(-5) M/l). Local ACE inhibition in these ischemic hearts antagonized ANG I but not ANG II effects and enhanced BK effects. The BK antagonist D-Arg-(Hyp2, Thi5,8, D-Phe7)BK abolished the beneficial effects of BK, ramipril, and ramiprilat. Increased concentrations of BK or ramiprilat were able to reverse the antagonism. The antiarrhythmic agent nicainoprol, a fast-sodium-channel blocking drug (class Ib), also protected isolated rat hearts against reperfusion arrhythmias, but was without beneficial effects on cardiac hemodynamics and biochemical parameters, in contrast to the ACE inhibitor. These results suggest that the beneficial effects of the ACE inhibitor ramipril on digoxin and reperfusion arrhythmias are not mediated by their direct actions on ionic channels in the cell membrane. It seems that other factors are responsible for its beneficial effects on reperfusion arrhythmias, cardiac function, and metabolism, which are associated with a reduction in ANG II generation and BK degradation by local ACE inhibition in the heart.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535056     DOI: 10.1007/bf01869575

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  35 in total

1.  Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat.

Authors:  K Li; X Chen
Journal:  J Mol Cell Cardiol       Date:  1987-09       Impact factor: 5.000

2.  Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism?

Authors:  W H van Gilst; J van Wijngaarden; E Scholtens; P A de Graeff; C D de Langen; H Wesseling
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

3.  Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498.

Authors:  W H van Gilst; P A de Graeff; H Wesseling; C D de Langen
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jul-Aug       Impact factor: 3.105

4.  [Noradrenaline release from the dog heart following temporary occlusion of a coronary artery].

Authors:  L Shahab; A Wollenberger; M Haase; U Schiller
Journal:  Acta Biol Med Ger       Date:  1969

5.  The effect of resting potential on the electrical activity of canine cardiac Purkinje fibers exposed to Na-free solution or to ouabain.

Authors:  R S Aronson; P F Cranefield
Journal:  Pflugers Arch       Date:  1974-01-11       Impact factor: 3.657

6.  Endothelium-derived relaxant factor inhibits platelet activation.

Authors:  R Busse; A Lückhoff; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

7.  Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres.

Authors:  W J Lederer; R W Tsien
Journal:  J Physiol       Date:  1976-12       Impact factor: 5.182

8.  Captopril in heart failure. A double blind controlled trial.

Authors:  J G Cleland; H J Dargie; G P Hodsman; S G Ball; J I Robertson; J J Morton; B W East; I Robertson; G D Murray; G Gillen
Journal:  Br Heart J       Date:  1984-11

9.  Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion.

Authors:  W H Van Gilst; P A De Graeff; J H Kingma; H Wesseling; C D De Langen
Journal:  Eur J Pharmacol       Date:  1984-04-13       Impact factor: 4.432

10.  Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts.

Authors:  W Linz; B A Schölkens
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

View more
  5 in total

Review 1.  ACE inhibitors and arrhythmias.

Authors:  R W Campbell
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 2.  ACE inhibitors for the treatment of myocardial ischemia?

Authors:  C Linder; G Heusch
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

Review 3.  Cardioprotection by ACE inhibitors in myocardial ischaemia/reperfusion. The importance of bradykinin.

Authors:  G Heusch; J Rose; T Ehring
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 4.  Role of calcium and other ions in reperfusion injury.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

Review 5.  Role of Oxidative Stress in the Genesis of Ventricular Arrhythmias.

Authors:  Adriana Adameova; Anureet K Shah; Naranjan S Dhalla
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.